Mitotane

Records for this ingredient, by country (identity only).

ATC L01XX23 · 9 markets · 11 records

Mitotane 9 markets · 11 records Forms
Filters

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

GB 2 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 500 mgtabletLysodrenManufacturer: Esteve Pharmaceuticals Ltd also in US·CA·CN
    +3Other 3 marketsESTWFR

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 500 mgtabletManufacturer: HRA Pharma RareDiseases also in US·GB·CA
    +3Other 3 marketsESTWFR

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 500 mgotherオペプリム

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 500 mgtabletLYSODREN 500 mg, comprimé also in US·GB·CA
    +3Other 3 marketsCNESTW
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.